4D Molecular Therapeutics, Inc. - COM (FDMT)

Historical Portfolio Holders from Q4 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
54.7 M
Holdings value Q1 2024
$1.74 B
Value change Q1 2024
+$452 M
Grand Portfolio weight change Q1 2024
+0.001%
Number of holders
142
Number of buys Q1 2024
99
Number of sells Q1 2024
-50
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
-0.001%
CUSIP
35104E100
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 54.7 M $1.74 B +$452 M $31.86 142
2023 Q4 40.9 M $828 M +$22.8 M $20.26 110
2023 Q3 41.9 M $533 M +$919 K $12.73 108
2023 Q2 41.2 M $745 M +$197 M $18.07 97
2023 Q1 30.4 M $522 M +$35 M $17.19 92
2022 Q4 28 M $622 M +$47.6 M $22.21 96
2022 Q3 22.8 M $183 M -$11.6 M $8.04 79
2022 Q2 24.6 M $172 M +$978 K $6.98 82
2022 Q1 25.3 M $382 M +$19.4 M $15.12 69
2021 Q4 23.4 M $513 M +$75.3 M $21.94 72
2021 Q3 18.8 M $505 M +$68.6 M $26.97 61
2021 Q2 16.2 M $389 M -$3.19 M $24.08 52
2021 Q1 15.4 M $665 M +$47.8 M $43.38 64
2020 Q4 13 M $536 M +$512 M $41.45 50